DYSPNOEA is the #2 most commonly reported adverse reaction for CICLESONIDE, manufactured by Covis Pharma US, Inc. There are 4,479 FDA adverse event reports linking CICLESONIDE to DYSPNOEA. This represents approximately 6.1% of all 74,022 adverse event reports for this drug.
Patients taking CICLESONIDE who experience dyspnoea should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
Reporting Frequency
DYSPNOEA4,479 of 74,022 reports
DYSPNOEA is moderately reported among CICLESONIDE users, representing a notable but not dominant share of adverse events.
Other Side Effects of CICLESONIDE
In addition to dyspnoea, the following adverse reactions have been reported for CICLESONIDE:
DYSPNOEA has been reported as an adverse event in 4,479 FDA reports for CICLESONIDE. This does not prove causation, but indicates an association observed in post-market surveillance data.
How common is DYSPNOEA with CICLESONIDE?
DYSPNOEA accounts for approximately 6.1% of all adverse event reports for CICLESONIDE, making it one of the most commonly reported side effect.
What should I do if I experience DYSPNOEA while taking CICLESONIDE?
If you experience dyspnoea while taking CICLESONIDE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.
Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.